Doxebo (doxorubicin-free Doxil-like liposomes) is safe to use as a pre-treatment to prevent infusion reactions to PEGylated nanodrugs
Author:
Funder
Hebrew University of Jerusalem
Academia Sinica
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference66 articles.
1. Cardiac safety of pegylated liposomal doxorubicin (Doxil/Caelyx) demonstrated by endomyocardial biopsy in patients with advanced malignancies;Gabizon;Cancer Investig.,2004
2. Safety aspects of pegylated liposomal doxorubicin in patients with cancer;Alberts;Drugs,1997
3. Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody;Szebeni;Circulation,1999
4. Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome;Szebeni;Nanomedicine,2012
5. Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals;Szebeni;Mol. Immunol.,2014
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nano-mupirocin as tumor-targeted antibiotic: Physicochemical, immunotoxicological and pharmacokinetic characterization, and effect on gut microbiome;Journal of Controlled Release;2024-09
2. Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies;ACS Nano;2024-08-09
3. Phospholipid Type Regulates Protein Corona Composition and In Vivo Performance of Lipid Nanodiscs;Molecular Pharmaceutics;2024-04-12
4. Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives;Chemical Engineering Journal;2024-04
5. Application of Nanoparticles for Magnetic Hyperthermia for Cancer Treatment—The Current State of Knowledge;Cancers;2024-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3